GlassScriptPhysician profile
Priya Sreedharan
NPI 1740392380
$681.03
in general payments reported to CMS, 2019-2025
7 companies · $45.21 in 2025
The $45.21 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2021: $155 · 2022: $251 · 2023: $14.46 · 2025: $45.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $154.68 | 2021 | |
| Abbott Laboratories | $134.50 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $119.32 | 2019 | |
| Lilly USA, LLC | $116.64 | 2022 | |
| Genentech USA, INC. | $96.22 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.91 | 2023-2025 | Hyqvia, Iclusig |
| Astellas Pharma US INC | $19.76 | 2025 | Vyloy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Sreedharan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.